| Product No | EMEA/H/C/000077 |
|---|---|
| Brand Name | Orlaam |
| Nonproprietary Name | levacetylmethadol |
| API | levacetylmethadol |
| ATC Code | N02AC |
| Indications | ORLAAM is indicated for the substitution maintenance treatment of opiate addiction in adults previously treated with methadone, as part of a comprehensive treatment plan including medical, social and psychological care.ORLAAM should be administered under the supervision of physicians with experience in addiction treatment and whenever practicable, in centres specialising in the treatment of drug addiction.ORLAAM is not intended for take home use. |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | Sipaco Internacional Lda. |
| Status | Withdrawn |
| Authorization Date | 1997-07-01 |
| Version | 0 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information